Eyestem Research, a Bangalore-based cell therapy company, is pleased to announce significant vision improvement in Phase 1 trials of its investigational drug, Eyecyte-RPEtm, in patients with ...

Average improvement of 14.9 letters in visual acuity reported in the first six patients over a four-six month follow-up. Signs of disease reversal observed in some patients. Dr Jogin Desai, Founder ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...